» Articles » PMID: 37528297

Is Lysosomal Acid Lipase Activity Associated with the Presence and Severity of Coronary Artery Disease?

Overview
Journal Herz
Date 2023 Aug 1
PMID 37528297
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lipid metabolism is considerably complex and there can be many critical steps in atherogenesis. The association between lysosomal acid lipase (LAL) activity and coronary artery disease (CAD) has not been elucidated in detail. We aimed to evaluate the association between LAL activity with the presence and severity of CAD in patients who are seen in daily clinical practice.

Methods: Patients who underwent coronary angiography were divided into groups according to the angiography results. Syntax scores and Gensini scores were calculated. The LAL activity was measured from dried blood spots.

Results: Median LAL activity values were similar in all study groups (normal coronary arteries: 0.40 nmol/punch/h; non-obstructive CAD: 0.44 nmol/punch/h; obstructive chronic CAD: 0.40 nmol/punch/h; obstructive acute coronary syndrome: 0.48 nmol/punch/h) and there was no correlation between coronary atherosclerotic burden and LAL activity (correlation coefficients Syntax score and LAL: -0.032; Gensini score and LAL: -0.030). In addition, no relationship between serum lipid levels and LAL activity was detected.

Conclusion: The presence of CAD and its severity is not associated with the LAL activity in patients encountered in daily clinical practice.

References
1.
Crisby M, Shah P, Yano J, Zhu J, Nilsson J . Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation. 2001; 103(7):926-33. DOI: 10.1161/01.cir.103.7.926. View

2.
Gao F, Wang Z, Ma X, Shen H, Yang L, Zhou Y . Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography. Lipids Health Dis. 2021; 20(1):106. PMC: 8436513. DOI: 10.1186/s12944-021-01528-3. View

3.
Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34):3227-3337. DOI: 10.1093/eurheartj/ehab484. View

4.
Pericleous M, Kelly C, Wang T, Livingstone C, Ala A . Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol Hepatol. 2017; 2(9):670-679. DOI: 10.1016/S2468-1253(17)30052-3. View

5.
Bernstein D, Hulkova H, Bialer M, Desnick R . Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol. 2013; 58(6):1230-43. DOI: 10.1016/j.jhep.2013.02.014. View